[HTML][HTML] Revised Korean Thyroid Association management guidelines for patients with thyroid nodules and thyroid cancer
KH Yi, YJ Park, SS Koong, JH Kim… - Endocrinology and …, 2010 - synapse.koreamed.org
한국원자력의학원 내과 1, 서울대학교 의과대학 내과 2, 병리과 7, 충북대학교 의학전문대학원
내과 3, 성균관대학교 의과대학 내과 13, 외과 4, 이비인후과 8, 휴먼영상의학센터 5 …
내과 3, 성균관대학교 의과대학 내과 13, 외과 4, 이비인후과 8, 휴먼영상의학센터 5 …
[HTML][HTML] Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
Introduction Triple negative breast cancer (TNBC) has a poorer survival, despite a higher
response rate to neoadjuvant chemotherapy. The purpose of this study was to identify the …
response rate to neoadjuvant chemotherapy. The purpose of this study was to identify the …
Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer
Purpose To evaluate the potential of diffusion-weighted (DW) magnetic resonance (MR)
imaging with an apparent diffusion coefficient (ADC) map in the prediction of response to …
imaging with an apparent diffusion coefficient (ADC) map in the prediction of response to …
Overexpression of peroxiredoxin in human breast cancer.
DY Noh, SJ Ahn, RA Lee, SW Kim, IA Park… - Anticancer …, 2001 - europepmc.org
The peroxiredoxins (Prx) are a family of 25 kDa peroxidases that can reduce H2O2 using an
electron from thioredoxin (Trx) or other substances. The mammalian Prx family is divided …
electron from thioredoxin (Trx) or other substances. The mammalian Prx family is divided …
Comparison of shear-wave and strain ultrasound elastography in the differentiation of benign and malignant breast lesions
JM Chang, JK Won, KB Lee, IA Park… - American Journal of …, 2013 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to compare the diagnostic performances of shear-
wave and strain elastography for the differentiation of benign and malignant breast lesions …
wave and strain elastography for the differentiation of benign and malignant breast lesions …
[HTML][HTML] Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical …
Background Prognostic factors in locally advanced breast cancer treated with neoadjuvant
chemotherapy differ from those of early breast cancer. The purpose of this study was to …
chemotherapy differ from those of early breast cancer. The purpose of this study was to …
Stiffness of tumours measured by shear-wave elastography correlated with subtypes of breast cancer
JM Chang, IA Park, SH Lee, WH Kim, MS Bae… - European …, 2013 - Springer
Objective To evaluate the correlation between stiffness values obtained by shear-wave
elastography (SWE) and breast cancer subtypes. Methods This was an institutional review …
elastography (SWE) and breast cancer subtypes. Methods This was an institutional review …
US of mammographically detected clustered microcalcifications
WK Moon, JG Im, YH Koh, DY Noh, IA Park - Radiology, 2000 - pubs.rsna.org
PURPOSE: To determine whether ultrasonography (US) can depict breast masses
associated with mammographically detected clustered microcalcifications and whether the …
associated with mammographically detected clustered microcalcifications and whether the …
[HTML][HTML] Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study
HJ An, KR Kim, IS Kim, DW Kim, MH Park, IA Park… - Modern pathology, 2005 - Elsevier
The role of human papilloma virus (HPV) infection in the development of cervical carcinoma
is well established, however, the prevalence of HPV DNA in cervical adenocarcinoma varies …
is well established, however, the prevalence of HPV DNA in cervical adenocarcinoma varies …
HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer
HJ Lee, AN Seo, EJ Kim, MH Jang… - American journal of …, 2014 - academic.oup.com
Objectives: Heterogeneity of HER2 gene amplification is found in a subset of breast cancers.
We investigated the impact of HER2 heterogeneity on trastuzumab responses and clinical …
We investigated the impact of HER2 heterogeneity on trastuzumab responses and clinical …